RE:A concern? With TH, you never know.......!
But why should they do such a deal for those "peanuts"....????? Be honest, 10 M $ ????
Or they wait or they do a deal for 100 M$ !!! So selling 50 M shares at 2 USD!!
And that would tell the market they have nothing in oncology yet and it would take way longer then predicted (is allready so...) to get some results out.
For now (and for me), "to wait" is the only option! Until now, little "positives" to tell the market.Hopefully soon they can tell us something.
Am waiting to buy back the shares i sold above 3 because the longer it takes, the less stellar results will be. It won't be a miracul drug, but it still can be "wonderfull" for oncology patients, really hope and pray it will be......!!!!!!
SPCEO1 - (10/30/2022 10:27:47 PM)
A concern?
I have heard THTX had good meetings with major shareholders post their third quarter results. Should any of those shareholders want to pickup additional shares of THTX, they would likely only do so through an offering. Could THTX sell shares to them via the ATM facility at these low prices. We know companies always find it pretty difficult to turn down alluring new money like this. I would be interested to know how people here feel about such a development should it occur. It would be good to let the company know before they pull the switch on such a deal if they are indeed considering it. We should have a voice in such a decision and we should let them hear it. Now, I am just speculating based on rather narrow info, but I suspect this is a risk. So, let's just assume a deal at $2 per share for 5 million new shares raising the company a new $10 million in equity capital just for argument's sake.
To me, doing such a deal would be quite worrisome as it would seem to indicate the data on TH-1902 is not looking good enough to hold off and do a deal once that data is available. Or, perhaps it indicates the phase 1b is going to take a lot longer than they are currently intimating and they need to boost the cash coffers to bridge until they get there.
On the positive side, we would likely get a new analyst report from Cantor if the ATM was used. But what can a new analyst say before we get phase 1b info.